2025 Fall Conference | C6 - Controversies in Neurology
| 01:00 PM - 01:45 PM PDT | Speaker |
Blood Pressure Targets in ICH: Should We Go Low?
Chitra Venkatasubramanian, MD, MBBS, MSc, FNCS, Kara R. Melmed, MD |
| 01:45 PM - 02:30 PM PDT | Speaker |
Should CGRP Antagonists Be First Line for Migraine Treatment?
Andrew Charles, MD, Rebecca C. Burch, MD |
| Chitra Venkatasubramanian, MD, MBBS, MSc, FNCS | Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell . Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKeen and associates. Dr. Venkatasubramanian has stock in Ceribell. The institution of Dr. Venkatasubramanian has received research support from Bard Inc. The institution of Dr. Venkatasubramanian has received research support from Biogen. The institution of Dr. Venkatasubramanian has received research support from NIH. The institution of Dr. Venkatasubramanian has received research support from Alnylam. |
| Kara R. Melmed, MD | Dr. Melmed has nothing to disclose. |
| Andrew Charles, MD | Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura. The institution of Dr. Charles has received research support from NIH. Dr. Charles has received publishing royalties from a publication relating to health care. Dr. Charles has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities. |
| Roneil Malkani, MD, FAAN | Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Weston Family Foundation. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Consultant with American Academy of Sleep Medicine. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with AANI. Dr. Malkani has a non-compensated relationship as a Board Member with Illinois Sleep Society that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Review editor on editorial board with Frontiers that is relevant to AAN interests or activities. |
| Rebecca C. Burch, MD | An immediate family member of Dr. Burch has received personal compensation for serving as an employee of Wellsky. Dr. Burch has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. An immediate family member of Dr. Burch has stock in Wellsky. Dr. Burch has received publishing royalties from a publication relating to health care. |